Patent holdings for IPC class C07J 71/00

Total number of patents in this class: 501

10-year publication summary

23
37
24
44
33
28
32
32
25
12
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Regeneron Pharmaceuticals, Inc.
4288
18
Nzp UK Limited
29
16
Reata Pharmaceuticals, Inc.
123
14
Sage Therapeutics, Inc.
364
14
Eli Lilly and Company
3848
13
Chiesi Farmaceutici S.p.A.
965
11
Beijing Peking University WBL Biotech Co. Ltd
30
9
Neupharma, Inc.
72
9
InterCept Pharmaceuticals, Inc.
206
8
Nicox Ophthalmics, Inc.
23
8
Scynexis, Inc.
69
8
AstraZeneca AB
2892
7
Socpra Sciences et Genie S.E.C.
197
7
Forendo Pharma Ltd.
18
6
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
829
6
GENETIC s.p.a.
12
6
Daiichi Sankyo Company, Limited
1877
5
Oncology Research International Limited
8
5
Duality Biologics (Suzhou) Co., Ltd.
43
5
Kimberly-clark Worldwide, Inc.
5502
4
Other owners 322